Related references
Note: Only part of the references are listed.A multicenter phase I trial of Interferon-β and Temozolomide Combination therapy for high-grade gliomas (INTEGRA Study)
Toshihiko Wakabayashi et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2008)
A combination of IFN-β and temozolomide in human glioma xenograft models:: implication of p53-mediated MGMT downregulation
Atsushi Natsume et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Phase II study of nimustine, carboplatin, vincristine, and interferon-β with radiotherapy for glioblastoma multiforme:: experience of the Kyoto Neuro-Oncology Group
Tomokazu Aoki et al.
JOURNAL OF NEUROSURGERY (2006)
Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas
H Ohgaki et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Human interferon beta, nimustine hydrochloride, and radiation therapy in the treatment of newly diagnosed malignant astrocytomas
T Watanabe et al.
JOURNAL OF NEURO-ONCOLOGY (2005)
Genetic pathways to glioblastoma:: A population-based study
H Ohgaki et al.
CANCER RESEARCH (2004)
Apoptosis and interferons: Role of interferon-stimulated genes as mediators of apoptosis
M Chawla-Sarkar et al.
APOPTOSIS (2003)
Initial and maintenance combination treatment with interferon-β, MCNU (Ranimustine), and radiotherapy for patients with previously untreated malignant glioma
T Wakabayashi et al.
JOURNAL OF NEURO-ONCOLOGY (2000)
Efficacy of post operative adjuvant therapy with human interferon beta, MCNU and radiation (IMR) for malignant glioma: Comparison among three protocols
N Hatano et al.
ACTA NEUROCHIRURGICA (2000)